The impact of migration on tuberculosis epidemiology and control in high-income countries: A review

BMC Medicine

Volumn 14, Issue 1, 2016, Pages 48-

  Pareek, Manish ^a,b   Greenaway, Christina ^c   Noori, Teymur ^d   Munoz, Jose ^e   Zenner, Dominik ^f,g  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Migration; Review; Screening; Tuberculosis

Indexed keywords

DNA;

AFRICA; AGE; ASIA; AUSTRALIA; BACTERIAL TRANSMISSION; CANADA; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; HEALTH ECONOMICS; HUMAN; INCIDENCE; LATENT TUBERCULOSIS; MIGRANT; MIGRATION; NEW ZEALAND; PREVALENCE; REVIEW; SCREENING; SEX; TRAVEL; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED KINGDOM; UNITED STATES; COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRY; INCOME; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRIES; EMIGRATION AND IMMIGRATION; HUMANS; INCOME; RISK FACTORS; TRAVEL; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84988566095     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0595-5     Document Type: Review

References (88)

1. World Health Organisation. WHO declares tuberculosis a global emergency. Soz Praventivmed. 1993;38:251-2.
2. World Health Organisation. Global tuberculosis report. Geneva: WHO; 2015.
3. Global Health Observatory Database. World Health Organisation, 2015. At http://apps.who.int/gho/data/?theme=main. Accessed 18 Dec 2015.
4. World Health Organisation Stop TB Partnership. The global plan to stop TB 2011-2015. Geneva: World Health Organisation; 2010.
5. EURO-TB. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2000. Saint-Maurice: European Commission; 2000.
6. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance in Europe 2013. Stockholm: European Centre for Disease Prevention and Control; 2015.
7. CDC. Reported tuberculosis in the United States. Atlanta: Department of Health and Human Services, CDC; 2015.
8. Japan Research Institute of Tuberculosis. Tuberculosis annual report 2013: TB in foreigners. Tokyo: JATA; 2013.
9. Public Health Agency of Canada. Tuberculosis in Canada 2013. Ottawa: Public Health Agency of Canada; 2015.
10. Toms C, Stapledon R, Waring J, Douglas P. Tuberculosis notifications in Australia 2012 and 2013. Commun Dis Intell. 2015;39:E217-35.
11. Institute of Environmental Science and Research Ltd (ESR). Tuberculosis in New Zealand: Annual Report 2013. Porirua: ESR; 2015.
12. Public Health England. Tuberculosis in the UK: 2014 report. London: Public Health England; 2014.
13. Greenaway C, Khan K, Schwartzman K. Tuberculosis surveillance and screening in selected high-risk populations. Ottawa: Public Health Agency of Canada; 2014.
14. United Nations Department of Economic and Social Affairs Population Division. International migration report 2013. Geneva: United Nations; 2013.
15. International Organisation for Migration. World migration report 2015. Geneva: IOM; 2015.
16. Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA. The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis. 2009;13:645-51.
17. Foreign-born population (indicator). 2016. At https://data.oecd.org/ migration/foreign-born-population.htm#indicator-chart. Accessed 19 Jan 2016.
18. Arshad S, Bavan L, Gajari K, Paget SNJ, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and metaanalysis. Eur Respir J. 2010;35:1336-45.
19. Klinkenberg E, Manissero D, Semenza JC, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J. 2009;34:1180-9.
20. Bothamley GH, Rowan JP, Griffiths CJ, et al. Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax. 2002;57:45-9.
21. Carvalho AC, Pezzoli MC, El-Hamad I, et al. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect. 2007;55:164-8.
22. Carvalho AC, Saleri N, El-Hamad I, et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect. 2005;133:179-85.
23. Gany FM, Trinh-Shevrin C, Changrani J. Drive-by readings: a creative strategy for tuberculosis control among immigrants. Am J Public Health. 2005;95:117-9.
24. Gibney KB, Mihrshahi S, Torresi J, Marshall C, Leder K, Biggs B-A. The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg. 2009;80:805-11.
25. Haley CA, Cain KP, Yu C, Garman KF, Wells CD, Laserson KF. Risk-based screening for latent tuberculosis infection. South Med J. 2008;101:142-9.
26. Hernandez-Garduno E, Elwood RK. The prevalence and predictors of tuberculin positivity in subjects screened for reasons other than contact investigation. Can Respir J. 2008;15:181-7.
27. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Contribution of a IFN-gamma assay in contact tracing for tuberculosis in a low-incidence, high immigration area. Swiss Med Wkly. 2008;138:585-93.
28. Li J, Munsiff SS, Agerton TB. Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health. 2010;12:816-22.
29. Orlando G, Merli S, Cordier L, et al. Interferon-γ releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection. 2010;38:195-204.
30. Richards B, Kozak R, Brassard P, Menzies D, Schwartzman K. Tuberculosis surveillance among new immigrants in Montreal. Int J Tuberc Lung Dis. 2005;9:858-64.
31. Saracino A, Scotto G, Fornabaio C, et al. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. New Microbiol. 2009;32:369-76.
32. Wells Charles D, Zuber Patrick LF, Nolan Charles M, Binkin Nancy J, Goldberg SV. Tuberculosis Prevention Among Foreign-born Persons in Seattle-King County, Washington. Am J Respir Crit Care Med. 1997;156:573-7.
33. Winje B, Oftung F, Korsvold G, et al. Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON(R)TB Gold with tuberculin skin test. BMC Infect Dis. 2008;8:65.
34. Lucas M, Nicol P, McKinnon E, et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax. 2010;65:442-8.
35. Minodier P, Vr L, Carle M-E, Blais D, Ovetchkine P, Tapiero B. Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children. J Infect Public Health. 2010;3:67-75.
36. Fortin K, Carceller A, Robert M, Chevalier I, Lamarre V, Lebel MH. Prevalence of positive tuberculin skin tests in foreign-born children. J Paediatr Child Health. 2007;43:768-72.
37. Méndez-Echevarría A, González-Muñoz M, Mellado MJ, et al. Interferon-γ release assay for the diagnosis of tuberculosis in children. Arch Dis Child. 2012;97(6):514-6.
38. Bodenmann P, Vaucher P, Wolff H, et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis. 2009;9:34.
39. Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP. Costeffectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax. 2010;65:178-80.
40. Kik SV, Franken WPJ, Arend SM, et al. Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009;13:820-8.
41. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and costeffectiveness analysis. Lancet Infect Dis. 2011;11:435-44.
42. Pareek M, Bond M, Shorey J, et al. Community-based evaluation of immigrant tuberculosis screening using interferon ? release assays and tuberculin skin testing: observational study and economic analysis. Thorax. 2013;68:230-9.
43. Liu Y, Posey DL, Cetron MS, Painter JA. Effect of a Culture-Based Screening Algorithm on Tuberculosis Incidence in Immigrants and Refugees Bound for the United StatesA Population-Based Cross-sectional StudyTB Screening in Immigrants and Refugees Bound for the United States. Ann Intern Med. 2015;162:420-8.
44. Campbell J, Krot J, Elwood K, Cook V, Marra F. A Systematic Review on TST and IGRA Tests Used for Diagnosis of LTBI in Immigrants. Mol Diagn Ther. 2015;19:9-24.
45. Campbell J, Chen W, Johnston J, et al. Latent Tuberculosis Infection Screening in Immigrants to Low-Incidence Countries: A Meta-Analysis. Mol Diagn Ther. 2015;19:107-17.
46. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis. 2002;8:679-84.
47. MacPherson DW, Gushulak BD. Balancing prevention and screening among international migrants with tuberculosis: population mobility as the major epidemiological influence in low-incidence nations. Public Health. 2006;120:712-23.
48. Marks GB, Bai J, Stewart GJ, Simpson SE, Sullivan EA. Effectiveness of postmigration screening in controlling tuberculosis among refugees: a historical cohort study, 1984-1998. Am J Public Health. 2001;91:1797-9.
49. Choudhury IW, West CR, Ormerod LP. The outcome of a cohort of tuberculinpositive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001. J Public Health. 2014;36:390-5.
50. Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW. Predictive values of QuantiFERON®-TB Gold testing in screening for tuberculosis disease in asylum seekers [Short communication]. Int J Tuberc Lung Dis. 2010;14:1209-11.
51. Marks GB, Bai J, Simpson SE, Sullivan EA, Stewart GJ. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med. 2000;162:1851-4.
52. Jeon CY, Murray MB. diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5, e152.
53. Cobelens FGJ, van Deutekom H, Draayer-Jansen IWE, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet. 2000;356:461-5.
54. McCarthy OR. Asian immigrant tuberculosis-the effect of visiting Asia. Br J Dis Chest. 1984;78:248-53.
55. Kik SV, Mensen M, Beltman M, et al. Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country. Int J Tuberc Lung Dis. 2011;15:38-43.
56. Maguire H, Dale JW, McHugh TD, et al. Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax. 2002;57:617-22.
57. Fok A, Numata Y, Schulzer M, FitzGerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies [Review Article]. Int J Tuberc Lung Dis. 2008; 12:480-92.
58. Diel R, Rusch-Gerdes S, Niemann S. Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany. J Clin Microbiol. 2004;42:2952-60.
59. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A. 2006;103:7042-7.
60. Currie CSWB, Cheng RC, Dye C. Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS. 2003;17:2501-8.
61. Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface. 2008;5:653-62.
62. Ziv E, Daley CL, Blower SM. Early therapy for latent tuberculosis infection. Am J Epidemiol. 2001;153:381-5.
63. Murray CJL, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A. 1998;95:13881-6.
64. World Health Organisation. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organisation; 2014.
65. Coker R, Bell A, Pitman R, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J. 2006;27:801-7.
66. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB. Tuberculosis control in Europe and international migration. Eur Respir J. 1994;7:1545-53.
67. Alvarez G, Gushulak B, Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis. 2010;11:3.
68. Alvarez GG, Clark M, Altpeter E, et al. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries. Int J Tuberc Lung Dis. 2010;14:1530-7.
69. Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012;18:1422-9.
70. Zenner D, Southern J, van Hest R, et al. Active case finding for tuberculosis among high-risk groups in low-incidence countries. Int J Tuberc Lung Dis. 2013;17:573-82. State of the art series. Case finding/screening. Number 3 in the series.
71. Aldridge RW, Yates TA, Zenner D, White PJ, Abubakar I, Hayward AC. Preentry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:1240-9.
72. Public Health England. UK pre-entry tuberculosis screening report 2014. London: Public Health England; 2014.
73. Public Health England. Tuberculosis in the UK: 2015 report. London: Public Health England; 2015.
74. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect. 2011;17:806-14.
75. Bettache N, Schwartzman K, Cnossen S, et al. Effectiveness of post-arrival latent tuberculosis screening programs in the foreign born: a systematic review and meta-analysis. In: B58 tuberculosis education and surveillance. San Francisco: American Thoracic Society; 2012. A3325-A.
76. Public Health England. Collaborative tuberculosis strategy for England 2014 to 2019. London: Public Health England; 2014.
77. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2000;162:2079-86.
78. Khan K, Muennig P, Behta M, Zivin JG. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med. 2002;347:1850-9.
79. Linas BP, Wong AY, Freedberg KA, Horsburgh CR Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011;184:590-601
80. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.
81. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2011.
82. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11:16-26.
83. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to lowprevalence countries. a cost-effectiveness analysis. Am J Respir Crit Care Med. 2000;161:780-9.
84. Iqbal AZ, Leighton J, Anthony J, Knaup RC, Peters EB, Bailey TC. Costeffectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis. Public Health Nurs. 2014;31:144-52.
85. Porco TC, Lewis B, Marseille E, Grinsdale J, Flood JM, Royce SE. Costeffectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health. 2006;6:157.
86. Zammarchi L, Casadei G, Strohmeyer M, et al. A scoping review of costeffectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries. BMC Health Serv Res. 2015;15:1-11.
87. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2009;93:69-84.
88. European Centre for Disease Prevention and Control. Evidence-based guidance: prevention of infectious diseases among newly arrived migrants in the EU/EEA. Stockholm: ECDC; 2015.